Search results

Narrow your search

Result types
Article type
Practice area
Industry sector

Showing 611 - 620 of 630 for "Life sciences" with applied filters

News & Analysis

IP people moves and firm announcements: Europe and Americas

05 September 2019 by Kingsley Egbuonu

Dentons, Stibbe, Bardehle Pagenberg, Rouse, Hogan Lovells, Antequera Parilli & Rodríguez, Eversheds Sutherland, and Lewis Silkin made firm announcements in the past few months

News & Analysis

Milbank welcomes four IP litigators in Los Angeles

17 August 2019 by Chris Adams and Kingsley Egbuonu

The firm hired four IP litigators, two of whom are ranked as patent stars, from a rival

News & Analysis

Patents for etanercept valid, says court

16 August 2019 by Chris Adams and Kingsley Egbuonu

In a highly-anticipated biologic patent dispute, the US District Court for the District of New Jersey has found that Amgen's patents for Enbrel® (etanercept) are valid. Two ranked firms are involved in this dispute

News & Analysis

Goodwin Procter continues to grow in London

14 August 2019 by Kingsley Egbuonu

The firm has hired another transactional lawyer to further strengthen its technology and life sciences practice

News & Analysis

Goodwin and Orrick acted in an iPSC technology acquisition

13 August 2019 by Kingsley Egbuonu

The firms advised on a transaction involving the acquisition of a biotech company valued at $1 billion

News & Analysis

IP protection for medical devices in India increases

31 July 2019 by Saya Choudhary Kapur and Vivek Ranjan

Saya Choudhary Kapur and Vivek Ranjan of Singh & Singh Law Firm examine the regulations surrounding medical devices in India and compare the law around patenting methods of treatment with that in the US and Europe

News & Analysis

The key regulatory matters affected by Brexit

05 June 2019 by Alexander Robinson and Stephen Garner

Alexander Robinson and Stephen Garner of Mathys & Squire explore some of the regulatory issues in the life sciences and pharmaceutical sectors that are likely to be affected by Brexit

News & Analysis

Proposed BPCIA reforms: More music, same dance

16 May 2019 by Paul A Ainsworth and Lauren A Watt

Paul A Ainsworth and Lauren A Watt of Sterne Kessler Goldstein & Fox examine the extent to which the proposed Biologic Patent Transparency Act will reduce patent thickets, increase transparency and competition in the biologics industry.

News & Analysis

Hogan Lovells hires life sciences attorneys from Venable

27 February 2019 by Managing Intellectual Property

Duo will join New York office, adding patent litigation expertise

News & Analysis

How to contact us

01 January 2019 by Managing IP

The contact details of our team